SEC Form 4 · accession 0001209191-15-066172
Arbutus Biopharma Corp · ABUS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vivek Ramaswamy
Director · 10% Owner
Period of report
Aug 12, 2015
Accepted (ET)
Aug 14, 2015 · 8:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001447028
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $9.11 | Aug 12, 2015 | A | 7,500 | A | — | Aug 12, 2025 | Common Stock | 7,500 | 7,500 | D |
Explanation of responses
- F1The shares underlying this option fully vested on August 12, 2015.